SABBY MANAGEMENT, LLC
Follow13F filer, CIK 1535610, MIAMI BEACH, FL
SABBY MANAGEMENT, LLC reported $9,018,641 across 21 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 90.96% of the portfolio.
Accepted , ingested 13F-HR 0001104659-26-126501
- Period
- 2026-09-30
- Reported value
- $9.02M
- Holdings
- 21
- Top 10 weight
- 90.96%
- New
- 8
- Sold out
- 10
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PNnew | +269,000 | $737K |
| YXTnew | +286,085 | $647K |
| ZVRAnew | +57,850 | $635K |
| APVOnew | +232,692 | $423K |
| IWMnew | +1,000 | $278K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SPYexited | -5,500 | -$4.11M |
| FAMIexited | -3,515,929 | -$840K |
| TPSTexited | -511,286 | -$568K |
| BIAFexited | -365,647 | -$297K |
| CREGexited | -127,774 | -$263K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001104659-26-126501, largest first. % of portfolio is the value over $6,690,050, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| TOYOTOYO CO LTD | 482,175 | $2.1M | 31.35% | -21,671 | Timeline | ||
| PNPN SMART ENERGY LTD | 269,000 | $737K | 11.02% | new | Timeline | ||
| YXTYXT COM GROUP HLDG LTD | 286,085 | $647K | 9.66% | new | Timeline | ||
| ZVRAZEVRA THERAPEUTICS INC | 57,850 | $635K | 9.49% | new | Timeline | ||
| CRVOCERVOMED INC | 199,678 | $593K | 8.86% | -49,202 | Timeline | ||
| APVOAPTEVO THERAPEUTICS INC | 232,692 | $423K | 6.33% | new | Timeline | ||
| IWMISHARES TR | 1,000 | $278K | 4.15% | new | Timeline | ||
| PAVSPARANOVUS ENTERTNMNT TECH LT | 64,671 | $261K | 3.9% | -10,769 | Timeline | ||
| SNESSENESTECH INC | 313,132 | $212K | 3.17% | +171,376 | Timeline | ||
| CPHICHINA PHARMA HLDGS INC | 308,360 | $203K | 3.03% | new | Timeline | ||
| CANFCAN FITE BIOFARMA LTD | 85,207 | $187K | 2.8% | new | Timeline | ||
| BCTXLBRIACELL THERAPEUTICS CORP | 136,365 | $158K | 2.36% | -54,018 | Timeline | ||
| SIDUSIDUS SPACE INC | 85,905 | $155K | 2.32% | +42,528 | Timeline | ||
| REVBREVELATION BIOSCIENCES INC | 126,915 | $104K | 1.55% | -83,667 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| SIDUS SPACE INCSIDUS SPACE INC CL A | put | 3,787 | $968K | +882 |
| ZEVRA THERAPEUTICS INCZEVRA THERAPEUTICS INC COM | put | 864 | $376K | +437 |
| STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T PUT | put | 405 | $333K | -320 |
| ISHARES TRISHARES TR PUT | put | 441 | $281K | 0 |
| STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T CALL | call | 400 | $205K | +195 |
| TOYO CO LTDTOYO CO LTD CALL | call | 1,001 | $108K | new |
| ISHARES TRISHARES TR CALL | call | 442 | $58.5K | 0 |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| SPYSTATE STR SPDR S&P 500 ETF T | 5,500 | $4.11M | shares |
| ABIVAX SAABIVAX SA | 82 | $1.09M | call |
| FAMIFARMMI INC | 3,515,929 | $840K | shares |
| TPSTTEMPEST THERAPEUTICS INC | 511,286 | $568K | shares |
| BIAFBIOAFFINITY TECHNOLOGIES INC | 365,647 | $297K | shares |
| CREGSMART POWERR CORP | 127,774 | $263K | shares |
| BCTXBRIACELL THERAPEUTICS CORP | 80,721 | $262K | shares |
| INMINMED PHARMACEUTICALS INC | 44,970 | $69.7K | shares |
| NUWENUWELLIS INC | 16,372 | $49.9K | shares |
| BCTXZBRIACELL THERAPEUTICS CORP | 120,802 | $11.5K | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-26-126501 | base | 2026-11-13 |